Shahin Zandieh | Medicine | Innovative Research Award

Prof. Dr. Shahin Zandieh | Medicine | Innovative Research Award

Professor | Hanusch-Krankenhaus | Austria

Prof. Dr. Shahin Zandieh is a medical imaging and diagnostic radiology specialist whose research spans musculoskeletal biomechanics, cardiovascular imaging, oncologic radiology, and advanced radiomics. With 49 publications, over 550 citations, and an h-index of 12, his scientific work reflects a strong interdisciplinary approach to clinical diagnosis, disease characterization, and imaging-guided evaluation of structural abnormalities. His contributions extend across orthopedic, cardiovascular, endocrine, and oncological systems through innovative use of MRI, CT, X-ray, and radiomic feature extraction.A notable component of Prof. Dr. Zandieh’s research focuses on orthopedic imaging and biomechanical assessment, including comparative studies such as the analysis of proximal chevron osteotomy versus Lapidus arthrodesis in managing hallux valgus deformities. His work provides clinically meaningful insights for surgeons, improving treatment selection, operative planning, and postoperative evaluation.In the field of cardiovascular imaging, he has explored rare cardiac pathologies such as “toothpaste tumor” manifestations of the mitral valve, enhancing the diagnostic awareness of uncommon presentations through multimodal radiologic evaluation. His studies also extend to endocrine-related morphologic changes, such as MRI-based radiomics used to detect cardiac variations influenced by autoimmune thyroid disorders—paving the way for AI-assisted diagnostic tools.Prof. Dr. Zandieh has also contributed to oncologic radiology, documenting rare metastatic patterns including giant ovarian metastasis from breast cancer. These case-based investigations broaden clinician understanding of atypical disease progression.Collectively, his research strengthens clinical imaging practice by integrating radiomics, rare-case documentation, biomechanics, and cross-system diagnostic strategies—advancing precision diagnosis, personalized treatment planning, and the broader field of radiological science.

Profiles: Scopus |ResearchGate

Featured Publications

Fezoulidis, N., Slavicek, J., Nonninger, J.-N., … , & Zandieh, S. (2025). Quantitative CT perfusion and radiomics reveal complementary markers of treatment response in HCC patients undergoing TACE.

Behanova, M., Sokhan, A., Haschka, J., … , & Kocijan, R. (2025). AI-supported opportunistic detection of vertebral fractures on routine CT scans: Diagnostic performance and clinical relevance.

Al-Taiee, B., Lamiss, M., Slavicek, J., … , & Zandieh, S. (2025). Disseminated miliary tuberculosis following intravesical BCG therapy: A rare but serious complication.

Kainz, B., Hergan, K., & Zandieh, S. (2025). Große Ovarialmetastase beim Mammakarzinom: Ein seltener Fall.

Prof. Dr. Shahin Zandieh’s work advances medical imaging by integrating radiomics, AI-supported diagnostics, and multimodal radiology to improve early disease detection, treatment response evaluation, and clinical decision-making. His contributions enhance patient safety, elevate diagnostic precision across oncology, cardiology, musculoskeletal, and infectious diseases, and support global healthcare innovation by translating advanced imaging technologies into practical, life-saving clinical applications.

Zixin Wang | Medicine | Best Researcher Award | 1743

Ms. Zixin Wang | Medicine | Best Researcher Award

Medical Student | Naval Medical University | China

Ms. Zixin Wang is an emerging researcher in the fields of tumor microenvironment biology and cancer immunotherapy, with a growing academic foundation in clinical medicine and surgical sciences. Her research interests are shaped by her training at the Second Military Medical University, where she pursued an undergraduate degree in Clinical Medicine (2021–2026), and her forthcoming academic engagement as a Master’s student in General Surgery at the Shanghai Medical College of Fudan University (2026–2029). Her academic trajectory reflects a strong commitment to translational oncology, integrating clinical insights with mechanistic research to improve therapeutic strategies for cancer patients. A key focus of Ms. Wang’s research is the tumor microenvironment (TME)—a complex cellular ecosystem that plays a decisive role in tumor progression, immune evasion, and treatment response. By studying the interactions between cancer cells, stromal components, and immune infiltrates, she aims to identify factors that influence immunotherapy effectiveness.Ms. Wang’s published work, “Mechanisms, advances, and challenges of immunotherapy in gastric cancer” in Frontiers in Immunology (2025), highlights her expertise in analyzing current and emerging immunotherapeutic modalities, including checkpoint inhibition, CAR-T cell therapy, and tumor vaccine development. Her scholarship examines both the molecular underpinnings and clinical bottlenecks of these therapies, with particular emphasis on the heterogeneity of gastric cancer, resistance pathways, and TME-driven immunosuppression.Through her interdisciplinary approach spanning clinical practice and immune-oncology research, Ms. Wang aims to contribute to the development of more precise, responsive, and personalized cancer treatments. Her evolving body of work positions her as a promising young scientist dedicated to advancing the future of surgical oncology and immunotherapeutic innovation.

Profiles: ORCID

Featured Publications

Wang, Z., & Wang, T. (2025). Mechanisms, advances, and challenges of immunotherapy in gastric cancer. Frontiers in Immunology, 16, Article 1639487.

Ms. Zixin Wang’s work advances the scientific understanding of the tumor microenvironment and improves the design of next-generation immunotherapies for gastric cancer, supporting the development of more precise and effective treatment strategies. Her research contributes to society by enabling earlier, more targeted, and less toxic cancer care, while also informing clinical innovation within the biomedical and healthcare industries. With a vision focused on translational impact, her efforts aim to accelerate global progress in cancer immunotherapy and personalized oncology.

 

Dimitrios Tsiachris | Medicine | Best Researcher Award

Assist. Prof. Dr. Dimitrios Tsiachris | Medicine | Best Researcher Award

EP and Pacing Lab Director | National and Kapodestrian University of Athens | Greece

Dr. D. L. Tsiachris is a highly accomplished cardiovascular researcher and clinician whose work has profoundly influenced the fields of cardiac electrophysiology and interventional cardiology. With an extensive research portfolio encompassing 224 scientific publications, 4,004 citations, and a Scopus h-index of 34, his contributions have advanced the understanding and management of complex cardiac rhythm disorders. His primary research interests lie in atrial fibrillation, ventricular arrhythmias, catheter ablation, and cardiac resynchronization therapy, with particular emphasis on novel energy-based interventions such as pulsed field ablation, cryoballoon technology, and radiofrequency systems. Dr. Tsiachris possesses exceptional research skills in clinical trial design, data synthesis, systematic reviews, and meta-analysis, enabling him to provide robust evidence supporting safer and more effective therapeutic strategies for patients with structural and electrical heart diseases. His investigations into leadless pacing systems, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, and the optimization of device-based therapies have contributed to personalized and precision-based cardiology. In addition, his studies on patient-reported outcomes and long-term ablation success rates bridge the gap between procedural innovation and patient-centered care. Recognized for his scientific leadership and collaborative excellence, Dr. Tsiachris has co-authored with more than 700 international researchers and continues to influence clinical practice guidelines through his impactful findings. Though his work is primarily published in high-impact journals such as Heart Rhythm, Europace, and Journal of Clinical Medicine, his commitment to advancing cardiovascular science stands as his greatest distinction. Honored for his research excellence and global contributions to electrophysiology, Dr. D. L. Tsiachris remains a driving force in redefining the standards of modern cardiac care through innovation, precision, and evidence-based practice.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Gatzoulis, K. A., Tsiachris, D., Arsenos, P., et al. (2019). Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: The PRESERVE EF study. European Heart Journal, 40(35), 2940–2949.

Gatzoulis, K. A., Vouliotis, A. I., Tsiachris, D., et al. (2013). Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: Reappraisal of the role of programmed ventricular stimulation. Circulation: Arrhythmia and Electrophysiology, 6(3), 504–512.

Gatzoulis, K. A., Tsiachris, D., et al. (2018). Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy. International Journal of Cardiology, 254, 175–181.

Silberbauer, J., Tsiachris, D., et al. (2014). Noninducibility and late potential abolition: A novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia. Circulation: Arrhythmia and Electrophysiology, 7(3), 424–435.

Della Bella, P., Tsiachris, D., et al. (2013). Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: Long-term outcome after ablation. Circulation, 127(13), 1359–1368.

Dr. Mokgata A. Matjie’s research advances human resource and organizational management by promoting fairness, emotional intelligence, and performance excellence. His work strengthens institutional effectiveness, employee well-being, and leadership accountability—driving innovation in workplace culture and public sector transformation globally.

Hugh Sampson | Medicine | Best Researcher Award

Dr. Hugh Sampson | Medicine | Best Researcher Award

Professor of Pediatrics | Icahn School of Medicine at Mount Sinai | United States

Dr. Hugh A. Sampson, MD, is a distinguished physician-scientist and pediatric immunologist best known for his pioneering contributions in food allergy and immunopathogenesis, and is currently the Kurt Hirschhorn Professor of Pediatrics and Director Emeritus of the Jaffe Food Allergy Institute at the Icahn School of Medicine at Mount Sinai. He earned a B.A. in Biology from Hamilton College in 1971, then obtained his M.D. from SUNY Buffalo in 1975, followed by a pediatric residency at Northwestern University / Children’s Memorial Hospital and an allergy/immunology fellowship at Duke University (1978–1980). Over his career, he has held leadership roles including chairing the Section on Allergy & Immunology of the American Academy of Pediatrics, serving as past President of AAAAI, holding editorial board positions in leading allergy/immunology journals, and directing national food allergy research consortia. His research interests encompass the pathogenesis of food-induced anaphylaxis, the molecular and immunologic characterization of allergenic food proteins and epitopes, genetics and immune regulation in food allergy, development of precision diagnostics (e.g. epitope-specific IgE/IgG4 profiles), and immunotherapy strategies (oral, epicutaneous, sublingual, and biologics such as anti-IgE) as well as novel therapeutic approaches. His research skills include translational and clinical trial design, immunologic assays (e.g. epitope mapping, serologic biomarkers), mechanistic in vitro and in vivo models, bioinformatics integration, large cohort epidemiologic and registry studies, and mentoring interdisciplinary teams. Among his many awards and honors are election to the National Academy of Medicine (Institute of Medicine) in 2003, the Brett Ratner Award from the American Academy of Pediatrics, the Distinguished Scientist Award of AAAAI, memberships in honorary societies (Alpha Omega Alpha, Sigma Xi), and repeated recognitions from Research.com as a top immunology scientist. According to his institutional profile, his h-index (based on Scopus/Pure) is listed at ~85,982 (which appears anomalous and may reflect internal counting metrics), while bibliometric sources more conservatively report an h-index of ~147 with over 800+ publications; traditional citation counts exceed 100,000 across his work. In conclusion, Dr. Sampson’s career exemplifies a remarkable integration of basic immunology and clinical translation: his leadership, mentorship, and sustained high-impact scholarship have shaped the modern field of food allergy research, spawning diagnostic and therapeutic innovations and training generations of investigators in allergy and immunology.

Profiles: Scopus | ORCID 

Featured Publications

  1. Rose, N. R., Milisauskas, V., & Sampson, H. A. (1975). Species-specific tissue antigens. III. Immunological relationships of enzymic antigens in various species. Clinical and Experimental Immunology, 20, 359–370.

  2. Sampson, H. A., & Buckley, R. H. (1981). Human IgE synthesis in vitro: A reassessment. Journal of Immunology, 127, 829–834.

  3. Rich, K. C., Sampson, H. A., Edwards, N. L., & Fox, I. H. (1981). Familial hypogammaglobulinemia with variable serum immunoglobulins: Concordance with lymphocyte ecto-5′-nucleotidase deficiency. American Journal of Diseases of Children, 135, 795–798.

  4. Sampson, H. A., Walchner, A., & Baker, P. (1981). Recurrent pyogenic infections in individuals with absence of the second component of complement. Journal of Clinical Immunology, 2, 39–45.

  5. LoGalbo, P. R., Sampson, H. A., & Buckley, R. H. (1982). Symptomatic giardiasis in three patients with X-linked agammaglobulinemia. Journal of Pediatrics, 101, 78–80.